Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

NCT04192487 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Healthy Volunteers
HIV/AIDS
HIV Diarrhea
Human Immunodeficiency Virus

Interventions

DRUG: Crofelemer delayed-release tablets 125mg

Sponsor

Napo Pharmaceuticals, Inc.